30 results on '"Berhane, Sarah"'
Search Results
2. The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival
3. Serum Levels of α-Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma
4. The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study
5. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
6. Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation
7. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
8. Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment
9. Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
10. Risk estimation for biliary tract cancer: Development and validation of a prognostic score
11. Diagnostic Models Combining Clinical Information, Ultrasound and Biochemical Markers for Ovarian Cancer: Cochrane Systematic Review and Meta-Analysis.
12. Adverse neurological events after sodium tetradecyl sulfate foam sclerotherapy – A prospective, observational study of 8056 treatments.
13. Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma.
14. Impact of direct‐acting antiviral agents on liver function in patients with chronic hepatitis C virus infection.
15. Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach.
16. Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.
17. Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials.
18. Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
19. Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.
20. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.
21. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.
22. The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers.
23. Systematic review of imaging tests to predict the development of rheumatoid arthritis in people with unclassified arthritis.
24. Adenovirus E1A interacts directly with, and regulates the level of expression of, the immunoproteasome component MECL1
25. THU497 - AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy.
26. Response to: Prognostication of HCC patients under sorafenib is not always possible.
27. Reply to: Correspondence concerning "Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection".
28. THU499 - Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma.
29. The chances of hepatic resection curing hepatocellular carcinoma.
30. THU498 - The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.